Healthcare | October 13, 2021
Supreem Pharma launches its superfoods division
It has planned an investment of over Rs 80 crore in the next five years
It has planned an investment of over Rs 80 crore in the next five years
The company plans to raise US $ 15 million
The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality
This opens up a huge market for the company’s Magnezis implants in India
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
Subscribe To Our Newsletter & Stay Updated
